BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
311 hedge funds and large institutions have $1.94B invested in BioTelemetry, Inc. in 2019 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 102 increasing their positions, 111 reducing their positions, and 35 closing their positions.
91% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 35
11% more funds holding
Funds holding: 281 → 311 (+30)
9% more capital invested
Capital invested by funds: $1.78B → $1.94B (+$161M)
8% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 111
14% less call options, than puts
Call options by funds: $25.4M | Put options by funds: $29.6M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.6M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$34.1M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$24.3M |
| 4 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$18.7M |
| 5 |
N
Natixis
Paris,
France
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$15.7M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$14.7M |
| 3 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
-$13.1M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$11M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
-$10.3M |
BEAT Hedge Fund Activity: Q1 2019 in Review
311 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q1 2019, worth a combined $1.94B — up 9% from $1.78B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new BEAT positions and 35 closed out — a net gain of 32 holders — while 102 added to existing stakes and 111 trimmed.
The largest buyer was Vanguard Group, adding an estimated $52.6M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $15.7M sold.
- 311 institutional investors held BioTelemetry, Inc. (BEAT) as of Q1 2019, up from 281 in Q4 2018.
- Funds reported $1.94B of BioTelemetry, Inc. stock for Q1 2019, up 9% quarter-over-quarter.
- 67 funds opened new BioTelemetry, Inc. positions in Q1 2019 and 35 closed out, a net change of +32 holders.
- The largest BioTelemetry, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $52.6M added.
- The largest BioTelemetry, Inc. seller in Q1 2019 was Renaissance Technologies, an estimated $15.7M sold.
Based on aggregated 13F filings for Q1 2019.